Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Safety and efficacy of filgotinib in Asian patients with active rheumatoid arthritis and prior inadequate response or intolerance to biologic DMARDs (bDMARD-IR) enrolled in a global phase 3 trial

Full metadata record
DC Field Value Language
dc.contributor.author배상철-
dc.date.accessioned2021-08-02T13:58:48Z-
dc.date.available2021-08-02T13:58:48Z-
dc.date.issued2019-05-16-
dc.identifier.urihttps://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/18466-
dc.titleSafety and efficacy of filgotinib in Asian patients with active rheumatoid arthritis and prior inadequate response or intolerance to biologic DMARDs (bDMARD-IR) enrolled in a global phase 3 trial-
dc.typeConference-
dc.citation.conferenceName제 39 차 춘계학술대회 및 제 13차 국제심포지엄-
dc.citation.conferencePlaceSeoul Dragon City, Seoul, Korea-
Files in This Item
There are no files associated with this item.
Appears in
Collections
서울 의과대학 > 서울 내과학교실 > 2. Conference Papers

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE